Sina Science and Technology News on the afternoon of September 25th, at the 2020 China Internet Pharmaceutical Health Summit Forum and 111 Inc Partnership Conference, Yu Gang, co-founder and executive chairman of 111 Inc, said that in the past five years and even in the next five years, the entire pharmaceutical and health industry will continue to grow at a growth rate of not less than 12%. Within ten years, the pharmaceutical and health industry will surpass the real estate and automobile industries to become the largest industry in China.
Liu Junling, co-founder, chairman and CEO of 111 Inc, also mentioned that 111 Inc, as a technology company, uses digital technology to organically connect patients with drugs and medical services. "at present, 111 Inc has created an ecosystem, including pharmaceutical companies, pharmaceutical distributors, drugstores, hospitals, doctors, insurance, and we empower all the participants in the ecosystem."
Yu Gang also pointed out that with the development of science and technology, phenomena such as inefficient and opaque circulation in the pharmaceutical industry are being changed, and scientific and technological empowerment is creating great value for the future of the industry, which is also the final impact of the Internet on the pharmaceutical and health industry. However, he also stressed that offline medical treatment is also indispensable, so the future must be organic integration online and offline.
During the meeting, 111 Inc and Guangzhou Xiangxue Pharmaceutical Co., Ltd. formally signed a strategic cooperation agreement, the two sides will deepen cooperation in the field of "Internet + Pharmaceutical". In addition, 111 Inc also signed strategic agreements with Agilent Technology (China) Co., Ltd., and Bayer Healthcare Co., Ltd.
111 Inc said that in the future, together with more industrial chain partners, we will continue to deepen the commercialization of omni-channel drugs, explore patient life cycle management solutions, and build a patient-centered and doctor-oriented, full-process digital and intelligent medical and health management service platform to make greater efforts to implement the mission of organically connecting patients with drugs and medical services with digital science and technology. (he Chang)